Prediction of Drug Concentration-Time Profiles in Children From Adults: An Allometric Approach

被引:1
|
作者
Mahmood, Iftekhar [1 ]
Goteti, Kosalaram [2 ,3 ]
机构
[1] US FDA, Dept Hematol, OBRR, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] MedImmune LLC, Clin Pharmacol, Gaithersburg, MD USA
[3] MedImmune LLC, DMPK, Gaithersburg, MD USA
关键词
pharmacokinetics; allometry; concentration-time profile; children; adults; TOTAL IV ANESTHESIA; ALFENTANIL PHARMACOKINETICS; CIMETIDINE; MIDAZOLAM; MORPHINE; KINETICS; AMIKACIN;
D O I
10.1097/MJT.0b013e318274df57
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main objective of this work was to evaluate 2 methods to predict concentration-time profiles of drugs in children (aged 5 years or older) from adult pharmacokinetic (PK) parameters. Five drugs from the literature were chosen for this study, and all these 5 drugs were described by a 2-compartment model in both adults and children. PK parameters (CL, V-c, V-ss, and V) were allometrically predicted in children from adults. PK constants such as A, B, , and were also predicted in children from adults as described in Appendix 1. Using predicted PK parameters and constants, concentration-time profiles of 5 drugs were predicted in children and compared with the observed profiles. Both methods of predictions provided fairly good prediction of concentration-time profiles in children. The predicted concentration-time profiles in children were comparable with the observed profiles and can be used to design first-in-children clinical trials.
引用
收藏
页码:132 / 140
页数:9
相关论文
共 50 条
  • [41] The Incorporation of Fractal Kinetics in the PK Modeling of Chemotherapeutic Drugs with Nonlinear Concentration-Time Profiles
    Akhter, Tahmina
    Sivaloganathan, Sivabal
    TRENDS IN BIOMATHEMATICS: MATHEMATICAL MODELING FOR HEALTH, HARVESTING, AND POPULATION DYNAMICS, 2019, : 231 - 254
  • [42] Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles
    Sauermann, R
    Karch, R
    Langenberger, H
    Kettenbach, J
    Mayer-Helm, B
    Petsch, M
    Wagner, C
    Sautner, T
    Gattringer, R
    Karanikas, G
    Joukhadar, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4448 - 4454
  • [43] Prediction of outcome following paraquat poisoning by arterial lactate concentration-time data
    Sun, Liang
    Li, Guo-Qiang
    Yan, Peng-Bo
    Liu, Yang
    Li, Guo-Feng
    Wei, Lu-Qing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (02) : 652 - 656
  • [44] Pharmacokinetic Modeling to Simulate the Concentration-Time Profiles After Dermal Application of Rivastigmine Patch
    Nozaki, Sachiko
    Yamaguchi, Masayuki
    Lefevre, Gilbert
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (07) : 2213 - 2221
  • [46] A MASS-SPECTROMETRIC METHOD FOR MEASURING FLAVOR CONCENTRATION-TIME PROFILES IN HUMAN BREATH
    SOETING, WJ
    HEIDEMA, J
    CHEMICAL SENSES, 1988, 13 (04) : 607 - 617
  • [47] PREDICTABILITY OF PLASMA CONCENTRATION-TIME PROFILES IN HUMANS USING CHIMERIC MICE WITH HUMANIZED LIVER
    Sanoh, Seigo
    Fujimoto, Mami
    Naritomi, Yoichi
    Sato, Koya
    Kawamura, Akio
    Horiguchi, Aya
    Sugihara, Kazumi
    Kitamura, Shigeyuki
    Horie, Toru
    Tateno, Chise
    Ohta, Shigeru
    DRUG METABOLISM REVIEWS, 2014, 45 : 60 - 60
  • [48] Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles
    Sauermann, R
    Karch, R
    Langenberger, H
    Kettenbach, J
    Mayer-Helm, B
    Petsch, M
    Wagner, C
    Sautner, T
    Gattringer, R
    Karanikas, G
    Joukhadar, C
    PHARMACOLOGY, 2005, 75 (04) : 204 - 204
  • [49] Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach
    Iftekhar Mahmood
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 53 - 59
  • [50] INVESTIGATION OF DISTRIBUTIONAL PROPERTIES OF PHARMACOKINETIC PARAMETERS VIA BOOTSTRAP-GENERATED PSEUDO CONCENTRATION-TIME PROFILES - A QUESTIONABLE APPROACH - REPLY
    STEYN, HS
    KOELEMAN, HA
    GOUWS, E
    RITSCHEL, WA
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (04) : 145 - 146